Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mehrdad Rahmaniyan"'
Autor:
Stefka D. Spassieva, Mehrdad Rahmaniyan, Jacek Bielawski, Christopher J. Clarke, Jacqueline M. Kraveka, Lina M. Obeid
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 5, Pp 918-928 (2012)
We applied a metabolic approach to investigate the role of sphingolipids in cell density-induced growth arrest in neuroblastoma cells. Our data revealed that sphingolipid metabolism in neuroblastoma cells significantly differs depending on the cells
Externí odkaz:
https://doaj.org/article/d076b921121046199bd366ade34e2c59
Autor:
Jacek Bielawski, Mehrdad Rahmaniyan, Duska Separovic, Alicja Bielawska, Jason S. Pierce, Mladen Korbelik, Kezhong Zhang, Jacqueline M. Kraveka, Jeremy S. DeLor, Li Li, Nithin B. Boppana
Publikováno v:
Anticancer Research. 37:455-464
Background/aim Combining an anticancer agent fenretinide (HPR) or C6-pyridinium ceramide (LCL29) with Foscan-mediated photodynamic therapy (FoscanPDT) is expected to augment anticancer benefits of each substance. We showed that treatment with FoscanP
Autor:
Yusuf A. Hannun, Mehrdad Rahmaniyan, Jacqueline M. Kraveka, Aiping Bai, Jacek Bielawski, Alicja Bielawska
Publikováno v:
Bioorganicmedicinal chemistry. 26(23-24)
The function of acid ceramidase (ACDase), whose congenital deficiency leads to Farber disease, has been recognized to be vital to tumor cell biology, and inhibition of its activity may be beneficial in cancer therapy. Therefore, manipulation of the a
Autor:
Paul Breen, Jacqueline M. Kraveka, Nithin B. Boppana, Jason S. Pierce, Li Li, Mehrdad Rahmaniyan, Jacek Bielawski, Nicholas Joseph, Mladen Korbelik, Aiping Bai, Alicja Bielawska, Tatyana I. Gudz, Eric Van Buren, Duska Separovic
Publikováno v:
International Journal of Oncology
Photodynamic therapy (PDT) is not always effective as an anticancer treatment, therefore, PDT is combined with other anticancer agents for improved efficacy. The combination of dasatinib and PDT with the silicone phthalocyanine photosensitizer Pc 4 w
Autor:
Jacqueline M. Kraveka, Lina M. Obeid, Mehrdad Rahmaniyan, Stefka D. Spassieva, Christopher J. Clarke, Jacek Bielawski
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 5, Pp 918-928 (2012)
We applied a metabolic approach to investigate the role of sphingolipids in cell density-induced growth arrest in neuroblastoma cells. Our data revealed that sphingolipid metabolism in neuroblastoma cells significantly differs depending on the cells
Publikováno v:
Journal of Biological Chemistry. 286:24754-24764
The dihydroceramide desaturase (DES) enzyme is responsible for inserting the 4,5-trans-double bond to the sphingolipid backbone of dihydroceramide. We previously demonstrated that fenretinide (4-HPR) inhibited DES activity in SMS-KCNR neuroblastoma c
Autor:
Michael B. Lilly, E. Ellen Jones, Ping Lu, Heather Venant, Jacqueline M. Kraveka, Christina Voelkel-Johnson, Mehrdad Rahmaniyan, Richard R. Drake, Elizabeth Garrett-Mayer, Charles D. Smith
Publikováno v:
Molecular cancer therapeutics. 14(12)
Despite recent advances in the development of novel therapies against castration-resistant prostate cancer, the advanced form of the disease remains a major treatment challenge. Aberrant sphingolipid signaling through sphingosine kinases and their pr
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 288:E753-E760
Studies were performed to further characterize the male-specific hepatic recombinant microsomal vitamin D 25-hydroxlase CYP2C11, expressed in baculovirus-infected insect cells, and determine whether it is also a vitamin D 24-hydroxylase. 25- and 24-h
Autor:
Paul, Breen, Nicholas, Joseph, Kyle, Thompson, Jacqueline M, Kraveka, Tatyana I, Gudz, Li, Li, Mehrdad, Rahmaniyan, Jacek, Bielawski, Jason S, Pierce, Eric, VAN Buren, Gaurav, Bhatti, Duska, Separovic
Publikováno v:
Anticancer research. 33(1)
Dihydroceramide desaturase 1 (DES) is the enzyme responsible for converting dihydroceramide into ceramide in the de novo sphingolipid biosynthesis pathway. Dihydroceramide can inhibit ceramide channel formation to interfere with apoptosis. We have sh
Publikováno v:
Cancer Research. 76:2479-2479
Background: Neuroblastoma is the most common solid tumor of infancy and third leading cause of cancer death in children. It has one of the lowest survival rates of all pediatric cancers with less than 50% survival in “high risk” disease. Curcumin